Recruiting Bladder Cancer Studies in Miami
Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)
This is a global, multicenter, randomized, open-label study, with an adaptive design. The main objective of the study is to measure the efficacy and safety of BT8009 (zelenectide pevedotin) as monothe...
Enfortumab Vedotin and Pembrolizumab in People with Bladder Cancer
This study will test whether enfortumab vedotin combined with pembrolizumab is an effective treatment for people with bladder cancer (urothelial carcinoma) involving the lymph nodes who are going to h...
About Bladder Cancer Clinical Trials in Miami
Bladder cancer occurs in the tissues of the bladder and is one of the most common cancers. It has a high recurrence rate, requiring ongoing monitoring. Treatments include surgery, intravesical therapy, chemotherapy, and immunotherapy.
There are currently 2 bladder cancer clinical trials recruiting participants in Miami, FL. These studies are seeking a combined 979 participants. Research is being sponsored by BicycleTx Limited, Memorial Sloan Kettering Cancer Center. Clinical trial participation is free and participants receive study-related medical care at no cost.
Bladder Cancer Clinical Trials in Miami — FAQ
Are there bladder cancer clinical trials in Miami?
Yes, there are 2 bladder cancer clinical trials currently recruiting in Miami, FL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Miami?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Miami research site will contact you about next steps.
Are clinical trials in Miami free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Miami studies also compensate for your time and travel.
What bladder cancer treatments are being tested?
The 2 active trials in Miami are testing new therapies including novel drugs, biologics, and treatment approaches for bladder cancer.
Data updated March 2, 2026 from ClinicalTrials.gov